Moloney Securities Asset Management LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Moloney Securities Asset Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,340 shares of the medical equipment provider's stock, valued at approximately $664,000.

A number of other large investors have also recently made changes to their positions in the company. Rehmann Capital Advisory Group boosted its stake in shares of Intuitive Surgical by 8.2% during the 1st quarter. Rehmann Capital Advisory Group now owns 1,658 shares of the medical equipment provider's stock worth $821,000 after purchasing an additional 125 shares during the period. Cornerstone Planning Group LLC boosted its position in Intuitive Surgical by 59.7% in the 1st quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider's stock valued at $56,000 after buying an additional 43 shares during the period. Dogwood Wealth Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $645,000. Linden Thomas Advisory Services LLC boosted its position in Intuitive Surgical by 4.3% in the 1st quarter. Linden Thomas Advisory Services LLC now owns 10,657 shares of the medical equipment provider's stock valued at $5,278,000 after buying an additional 440 shares during the period. Finally, Flossbach Von Storch SE purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $280,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 3.0%

NASDAQ:ISRG traded down $15.64 during trading hours on Friday, reaching $510.41. 1,324,034 shares of the company were exchanged, compared to its average volume of 1,674,258. The stock's 50-day moving average is $538.20 and its 200-day moving average is $536.86. The firm has a market cap of $182.94 billion, a PE ratio of 74.92, a price-to-earnings-growth ratio of 5.60 and a beta of 1.64. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the business earned $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research reports. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Royal Bank Of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $592.59.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.